Olivo_2008_Clin.Dev.Immunol_2008_794050

Reference

Title : Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages - Olivo_2008_Clin.Dev.Immunol_2008_794050
Author(s) : Olivo RA , Nascimento NG , Teixeira CF , Silveira PF
Ref : Clin Dev Immunol , 2008 :794050 , 2008
Abstract :

Analysis of the effects of cyclosporine A (25-28 mgkg(-1)) and/or methotrexate (0.1 mgkg(-1)) treatments on dipeptidyl peptidase IV (DPPIV) and prolyl oligopeptidase (POP) activities and on algesic response in two distinct status of murine macrophages (Mphis) was undertaken. In resident Mphis, DPPIV and POP were affected by neither individual nor combined treatments. In thioglycolate-elicited Mphis, methotrexate increased DPPIV (99-110%) and POP (60%), while cyclosporine inhibited POP (21%). Combined treatment with both drugs promoted a rise (51-84%) of both enzyme activities. Only cyclosporine decreased (42%) the tolerance to algesic stimulus. Methotrexate was revealed to exert prevalent action over that of cyclosporine on proinflammatory Mphi POP. The opposite effects of methotrexate and cyclosporine on POP activity might influence the availability of the nociceptive mediators bradykinin and substance P in proinflammatory Mphis. The exacerbated response to thermally induced algesia observed in cyclosporine-treated animals could be related to upregulation of those mediators.

PubMedSearch : Olivo_2008_Clin.Dev.Immunol_2008_794050
PubMedID: 18354729

Related information

Citations formats

Olivo RA, Nascimento NG, Teixeira CF, Silveira PF (2008)
Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages
Clin Dev Immunol 2008 :794050

Olivo RA, Nascimento NG, Teixeira CF, Silveira PF (2008)
Clin Dev Immunol 2008 :794050